Researchers frequently utilize bacteriostatic water for reconstituting lyophilized peptides and preparing sterile laboratory solutions under regulated handling conditions
For medical professionals considering BPC-157 in clinical practice, current use must acknowledge the investigational nature of the peptide and proceed within appropriate ethical frameworks including informed consent, safety monitoring, and outcome documentation
That decision is part of the safety process and is made for the client's well-being
PMC 3251652
[DOI] [PubMed] [Google Scholar] Roum JH, Buhl R, McElvaney NG, Borok Z, Crystal RG
In 2023, the FDA moved 19 popular peptides to Category 2, citing concerns about immunogenicity risk, peptide-related impurities, and limited human safety data